Patents by Inventor Daryl L. Thompson

Daryl L. Thompson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240082277
    Abstract: A composition N,N-dimethyl-2-((methyldiphenylsilyl)oxy)ethan-1-amine having anti-inflammatory properties. The composition is effective for treating various infections including those which have a pro-inflammatory response.
    Type: Application
    Filed: August 18, 2022
    Publication date: March 14, 2024
    Inventor: Daryl L. THOMPSON
  • Publication number: 20240084112
    Abstract: A bioplastic additive and antimicrobial plastic includes a polyphenol and an organic polymer. The polyphenol may be a phenol, polyphenol, bioflavenoid, flavonoid, tannin, coumarin, lagman, quinone, stibene or qurcuminoidstenin. The organic polymer may be chitosan, chitin, cellulose and keratin. In one advantageous form, the polyphenol is hesperidin and the organic biopolymer is chitosan.
    Type: Application
    Filed: August 23, 2022
    Publication date: March 14, 2024
    Inventor: Daryl L. THOMPSON
  • Publication number: 20230165831
    Abstract: Method and composition for treating or limiting the occurrence of cancer includes combining a polyphenol with a chemotherapeutic agent. Advantageously, the polyphenol may be myricetin including halogenated myricetin such as mono- or dichlorinated myricetin and the chemotherapeutic agent includes but is not limited to paclitaxel, doxorubicin, topotecan and cisplatin. The polyphenol such as myricetin including halogenated such as chlorinated myricetin can be combined in a single pharmaceutical composition with chemotherapeutic agent or a method can be coadministering separate compositions of a polyphenol and a therapeutic agent to treat or limit the occurrence of cancer.
    Type: Application
    Filed: November 19, 2021
    Publication date: June 1, 2023
    Inventor: Daryl L. THOMPSON
  • Publication number: 20220401403
    Abstract: A method and composition for treating viral infections using a combination of naturally occurring compounds is provided. The method includes administering to a patient at risk of or diagnosed with a viral infection a composition including therapeutically effective amounts of a myricetin and hesperitin to treat viral infections include coronavirus.
    Type: Application
    Filed: June 14, 2021
    Publication date: December 22, 2022
    Inventor: Daryl L. THOMPSON
  • Publication number: 20220159950
    Abstract: A composition and method for insect repellent is provided. The composition in one form has on a weight percentage basis 2-4% ?-pinene; 2-4% borneol; 8-10% geraniol; 28-35% linalool; 25-38% linalyl acetate; 1-4% methyl salicylate; 2-4% myrcene; 2-4% para-cymene; 4-8% phellandrene; 1-4% thymol; and 2-4% vanillin. The composition has insect repellent properties.
    Type: Application
    Filed: February 14, 2022
    Publication date: May 26, 2022
    Inventors: Daryl L. THOMPSON, Thomas A. Meyer, Nicholas A. Van Rees
  • Patent number: 11246310
    Abstract: A composition and method for insect repellent is provided. The composition in one form has on a weight percentage basis 2-4% ?-pinene; 2-4% borneol; 8-10% geraniol; 28-35% linalool; 25-38% linalyl acetate; 1-4% methyl salicylate; 2-4% myrcene; 2-4% para-cymene; 4-8% phellendrene; 1-4% thymol; and 2-4% vanillin. The composition has insect repellent properties.
    Type: Grant
    Filed: February 8, 2019
    Date of Patent: February 15, 2022
    Assignee: GLOBAL BIOLIFE INC.
    Inventors: Daryl L. Thompson, Thomas A. Meyer, Nicholas A. Van Rees
  • Publication number: 20210299088
    Abstract: A method and composition for treating viral infections using a combination of naturally occurring compounds is provided. The method includes administering to a patient at risk of or diagnosed with a viral infection a composition including therapeutically effective amounts of a myricetin and hesperitin to treat viral infections include coronavirus.
    Type: Application
    Filed: June 14, 2021
    Publication date: September 30, 2021
    Inventor: Daryl L. THOMPSON
  • Publication number: 20210100243
    Abstract: A composition and method for insect repellent is provided. The composition in one form has on a weight percentage basis 10-20% 2,6-dimethyl-7-octen-2-ol; 0.1-5% 2,6-octadienal, 3,7-dimethyl-; 1-10% benzyl benzoate; 0.01-2% citral; 1-10% hexamethylindanopyran; 10-40% lavender oil; 20-50% Lemon Oil Argentina; 5-15% Lime Oil Distilled Mexican; 0.01-3% limonene; 5-15% rosemary oil; and optionally 0.1-10% an insect repellent active ingredient selected from the group consisting of N,N-Diethyl-meta-toluamide (DEET), ethyl butylacetylaminopropionate and picaridin. The composition has insect repellent properties.
    Type: Application
    Filed: October 4, 2019
    Publication date: April 8, 2021
    Inventors: Daryl L. THOMPSON, Scott M. TRUESDELL
  • Patent number: 10966424
    Abstract: A composition and method for insect repellent is provided. The composition in one form has on a weight percentage basis 10-20% 2,6-dimethyl-7-octen-2-ol; 0.1-5% 2,6-octadienal, 3,7-dimethyl-; 1-10% benzyl benzoate; 0.01-2% citral; 1-10% hexamethylindanopyran; 10-40% lavender oil; 20-50% Lemon Oil Argentina; 5-15% Lime Oil Distilled Mexican; 0.01-3% limonene; 5-15% rosemary oil; and optionally 0.1-10% an insect repellent active ingredient selected from the group consisting of N,N-Diethyl-meta-toluamide (DEET), ethyl butylacetylaminopropionate and picaridin. The composition has insect repellent properties.
    Type: Grant
    Filed: October 4, 2019
    Date of Patent: April 6, 2021
    Assignee: GLOBAL BIOLIFE INC.
    Inventors: Daryl L. Thompson, Scott M. Truesdell
  • Publication number: 20200253199
    Abstract: A composition and method for insect repellent is provided. The composition in one form has on a weight percentage basis 2-4% ?-pinene; 2-4% borneol; 8-10% geraniol; 28-35% linalool; 25-38% linalyl acetate; 1-4% methyl salicylate; 2-4% myrcene; 2-4% para-cymene; 4-8% phellendrene; 1-4% thymol; and 2-4% vanillin. The composition has insect repellent properties.
    Type: Application
    Filed: February 8, 2019
    Publication date: August 13, 2020
    Inventors: Daryl L. THOMPSON, Scott M. Truesdell, Thomas A. Meyer, Nicholas A. Van Rees
  • Publication number: 20200179299
    Abstract: A composition comprises ?-pinene, borneol, cinnamic aldehyde, citral, d-limonene, eucalyptol, eugenol, farnesol, linalool, thymol, and vanillin. In addition, a method for use of the composition as an antibacterial and antiviral agent is also disclosed.
    Type: Application
    Filed: December 7, 2018
    Publication date: June 11, 2020
    Inventors: Daryl L. THOMPSON, Scott M. TRUESDELL, Nicholas A. VAN REES, Thomas A. MEYER
  • Patent number: 6319711
    Abstract: An antiretroviral composition for inhibiting the action of reverse transcriptase include a nucleoside analog containing a six-carbon levo hexose sugar, for example, L-rhamnose or L-fucose. Treatment is achieved by delivering the antiretroviral to the infected system, wherein the reverse transcription process is inhibited via steric hindrance, halting the viral RNA replication. Delivery may be accomplished by conventional methods, such as via oral dosing or injection. Additional delivery methods are also contemplated, including packaging in liposomes and protein targeting. The composition and method are also useful for inhibiting the proliferation of cancer cells by halting the transcription process.
    Type: Grant
    Filed: June 28, 2000
    Date of Patent: November 20, 2001
    Assignee: Promelas Research Corporation
    Inventors: Timothy N. Tillman, Daryl L. Thompson, Gordon J. Rafool
  • Patent number: 6090602
    Abstract: An antiretroviral composition for inhibiting the action of reverse transcriptase include a nucleoside analog containing a six-carbon levo hexose sugar, for example, L-rhamnose or L-fucose. Treatment is achieved by delivering the antiretroviral to the infected system, wherein the reverse transcription process is inhibited via steric hindrance, halting the viral RNA replication. Delivery may be accomplished by conventional methods, such as via oral dosing or injection. Additional delivery methods are also contemplated, including packaging in liposomes and protein targeting. The composition and method are also useful for inhibiting the proliferation of cancer cells by halting the transcription process.
    Type: Grant
    Filed: February 18, 1998
    Date of Patent: July 18, 2000
    Assignee: Promelas Research Corporation
    Inventors: Timothy N. Tillman, Daryl L. Thompson, Gordon J. Rafool